Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06189755 · ClinicalTrials.gov registry record
MicroRNAs as Biomarkers for Obstructive Sleep Apnea
A clinical trial of Obstructive Sleep Apnea, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 500
- Enrollment target
- 3
- Study locations
NCT06189755: Recruiting study of Obstructive Sleep Apnea, sponsored by University of Pennsylvania.
NCT06189755 is a study of Obstructive Sleep Apnea that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 500 participants, above the 218-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (129% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06189755, a study of Obstructive Sleep Apnea, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 3
- Study locations
Study Summary
Although obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop and validate blood biomarkers that are specific to OSA, useful for identification of cases with OSA, reflective of efficacy of therapy, and able to predict blood pressure response to treatment of OSA.
Primary Outcome
Changes in circulating microRNA profile
Conditions Studied
Interventions
- DEVICE Positive Airway Pressure
Study Locations (3)
Ohio
- The Ohio State University - Martha Morehouse Medical Pavilion, Suite 2600 - Columbus
Pennsylvania
- University of Pennsylvania - Philadelphia
Other
- University of Iceland - Reykjavik
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2028-04-30 |
What NCT06189755 shows while recruiting
NCT06189755 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 218-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (129% higher).
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Positive Airway Pressure is the first listed.
NCT06189755 reports a single indexed study location in Ohio, Pennsylvania, Other.
Frequently Asked Questions
What is clinical trial NCT06189755 about?
NCT06189755 is a clinical study titled "MicroRNAs as Biomarkers for Obstructive Sleep Apnea". Although obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop and validate blood biomarkers that are specific to OSA, useful for identification of cases with OSA, r...
What is the current status of trial NCT06189755?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-04-01. Estimated completion is 2028-04-30.
What conditions does trial NCT06189755 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
What interventions are being tested in trial NCT06189755?
The interventions under investigation include: Positive Airway Pressure (DEVICE).
Who is sponsoring clinical trial NCT06189755?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06189755 being conducted?
This trial has 3 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06189755's enrollment target sits among peer trials
500 14th of 155 higher than 142 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
RECRUITING · Phase 1
-
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
RECRUITING
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI